By Professor Ann McCormack

Journal articles

Lenders NF; Inder WJ; McCormack AI, 2021, 'Towards precision medicine for clinically non-functioning pituitary tumours', Clinical Endocrinology, 95, pp. 398 - 409, http://dx.doi.org/10.1111/cen.14472

Chang N; Grayson JW; Mangussi-Gomes J; Fung S; Alvarado R; Winder M; Jonker BP; McCormack A; Harvey RJ, 2021, 'Assessment of magnetic resonance imaging criteria for the diagnosis of cavernous sinus invasion by pituitary tumors', Journal of Clinical Neuroscience, 90, pp. 262 - 267, http://dx.doi.org/10.1016/j.jocn.2021.06.010

Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI, 2021, 'Transcription Factor Immunohistochemistry in the Diagnosis of Pituitary Tumors', Journal of the Endocrine Society, 5, pp. A651 - A651, http://dx.doi.org/10.1210/jendso/bvab048.1327

Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI, 2021, 'Transcription factor immunohistochemistry in the diagnosis of pituitary tumours', European Journal of Endocrinology, 184, pp. 891 - 901, http://dx.doi.org/10.1530/EJE-20-1273

Lamb LS; Sim HW; McCormack AI, 2020, 'Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy', Frontiers in Endocrinology, 11, pp. 576027, http://dx.doi.org/10.3389/fendo.2020.576027

Stroud A; Dhaliwal P; Alvarado R; Winder MJ; Jonker BP; Grayson JW; Hamizan A; Harvey RJ; McCormack A, 2020, 'Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis', Pituitary, 23, pp. 595 - 609, http://dx.doi.org/10.1007/s11102-020-01066-8

Fleseriu M; Buchfelder M; Cetas JS; Fazeli PK; Mallea-Gil SM; Gurnell M; McCormack A; Pineyro MM; Syro LV; Tritos NA; Marcus HJ, 2020, 'Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective', Pituitary, 23, pp. 327 - 337, http://dx.doi.org/10.1007/s11102-020-01059-7

Wang M; Jonker B; Killen L; Bogum Y; McCormack A; Bishay RH, 2020, 'Fatal high-grade skull osteosarcoma 30 years following radiotherapy for Cushing’s disease', Endocrinology Diabetes and Metabolism Case Reports, 2020, pp. 1 - 7, http://dx.doi.org/10.1530/EDM-20-0062

Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C, 2020, 'Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions', Reviews in Endocrine and Metabolic Disorders, 21, pp. 243 - 251, http://dx.doi.org/10.1007/s11154-020-09562-9

Burman P; Lamb L; McCormack A, 2020, 'Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives', Reviews in Endocrine and Metabolic Disorders, 21, pp. 263 - 276, http://dx.doi.org/10.1007/s11154-020-09551-y

Cho J; Grayson JW; Christensen J; Winder MJ; Sheehy J; Steel T; Bentivoglio P; Barham HP; McCormack A; Harvey RJ, 2020, 'Long-Term Sinonasal Function Following Transnasal Pituitary Surgery: A Comparison of Surgical Approach', American Journal of Rhinology and Allergy, 34, pp. 361 - 368, http://dx.doi.org/10.1177/1945892419896788

Lenders NF; McCormack AI; Ho KKY, 2020, 'Management of endocrine disease: Does gender matter in the management of acromegaly?', European Journal of Endocrinology, 182, pp. R67 - R82, http://dx.doi.org/10.1530/EJE-19-1023

Lamb LS; Sim HW; McCormack AI, 2020, 'Exploring the role of novel medical therapies for aggressive pituitary tumors: A review of the literature—“are we there yet?”', Cancers, 12, pp. 308, http://dx.doi.org/10.3390/cancers12020308

De Sousa SMC; Baranoff J; Rushworth RL; Butler J; Sorbello J; Vorster J; Thompson T; Mccormack AI; Inder WJ; Torpy DJ, 2020, 'Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors', Journal of Clinical Endocrinology and Metabolism, 105, http://dx.doi.org/10.1210/clinem/dgz076

Grayson JW; Nayak A; Winder M; Jonker B; Alvarado R; Barham H; Mccormack A; Harvey RJ, 2019, 'Multidisciplinary Team Care in the Surgical Management of Pituitary Adenoma', Journal of Neurological Surgery Part B Skull Base, 82, pp. 295 - 302, http://dx.doi.org/10.1055/s-0039-1700498

McCabe M; Gauthier M-E; Chan C-L; Thompson T; De Sousa S; Puttick C; Grady J; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas M; kConFab ; Lord R; Johns A; Kohonen-Corish M; O'Toole S; Clark J; Mueller S; Gupta R; McCormack A; Dinger M; Cowley M; Bastick P; Friedlander M; Colley A; Andrews L; Young M-A; Tucker K; Williams R; Aghmesheh M, 2019, 'Development and validation of a targeted gene sequencing panel for application to disparate cancers', Scientific Reports, 9, pp. 17052, http://dx.doi.org/10.1038/s41598-019-52000-3

McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MEA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ; Wong-Erasmus M, 2019, 'Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases', Cold Spring Harbor Molecular Case Studies, 5, pp. a003764, http://dx.doi.org/10.1101/mcs.a003764

Stroud A; Zhang J; McCormack A, 2019, 'Diagnosing Cushing's disease in the context of chronic kidney disease: a case report and literature review.', Eur J Endocrinol, 181, pp. K29 - K35, http://dx.doi.org/10.1530/EJE-19-0326

Trainer PJ; Newell-Price JDC; Ayuk J; Aylwin SJB; Rees A; Drake W; Chanson P; Brue T; Webb SM; Fajardo C; Aller J; McCormack AI; Torpy DJ; Tachas G; Atley L; Ryder D; Bidlingmaier M, 2018, 'A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly', European Journal of Endocrinology, 179, pp. 97 - 108, http://dx.doi.org/10.1530/EJE-18-0138

Trouillas J; Burman P; McCormack A; Petersenn S; Popovic V; Dekkers O; Raverot G, 2018, 'Aggressive pituitary tumours and carcinomas: Two sides of the same coin?', European Journal of Endocrinology, 178, pp. C7 - C9, http://dx.doi.org/10.1530/EJE-18-0250

Lenders N; McCormack A, 2018, 'Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)', Pituitary, 21, pp. 217 - 229, http://dx.doi.org/10.1007/s11102-017-0857-z

McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P; Harrison A; Hubalewska-Dydejezky A; Assie G; Bach L; Batisse-Lignier M; Berinder K; Bilbao I; Bonnet F; Bresson D; Bruno O; Campdera M; Caron P; Castinetti F; Ceccato F; Chabre O; Chanson P; Christ E; Cloix L; Cortet C; Criniere L; Cuatrecasas G; Debono M; Delemer B; Desailloud R; Deutschbein T; Dusek T; Engström BE; Faustini-Fustini M; Franck S; Garcia C; Greenman Y; Gil SM; Mantovani G; Gurnell M; Heaney A; Henley D; Higham C; Hoving EW; Höybye C; Ichihara A; Jaffrain-Rea ML; Johannsson G; Jorgensen JOL; Jublanc C; Komor J; Korbonits M; Kralievic I; Larrieu-Ciron D; Lasolle H; Laws E; Losa M; Maiter D; Marcocci C; Marques OC; Mazzuco TL; Micko A; Bourcigaux N; Neggers S; Newell-Price J; Perez-Berida B; Ortiz LD; Ragnarsson O; Ragonese M; Reincke M; Sadoul JL; Shimatsu A; Syro LV; Taillandier L; Toth M; Usui T; Valkusz Z; Vila G; Whitelaw B; Zatelli MC, 2018, 'Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016', European Journal of Endocrinology, 178, pp. 265 - 276, http://dx.doi.org/10.1530/EJE-17-0933

Raverot G; Burman P; McCormack A; Heaney A; Petersenn S; Popovic V; Trouillas J; Dekkers OM, 2018, 'European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas', European Journal of Endocrinology, 178, pp. G1 - G24, http://dx.doi.org/10.1530/EJE-17-0796

Sheriff N; McCormack AI, 2017, 'How useful is urinary-free cortisol in the clinic?', Biomarkers in Medicine, 11, pp. 1009 - 1016, http://dx.doi.org/10.2217/bmm-2016-0311

McCormack AI; Burt MG, 2017, 'Optimising pituitary surgery outcomes in Australia: how much does size matter?', Internal Medicine Journal, 47, pp. 1225 - 1227, http://dx.doi.org/10.1111/imj.13610

De Sousa SMC; McCormack AI; McGrath S; Torpy DJ, 2017, 'Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease', Clinical Endocrinology, 87, pp. 515 - 522, http://dx.doi.org/10.1111/cen.13401

Casanueva FF; Barkan AL; Buchfelder M; Klibanski A; Laws ER; Loeffler JS; Melmed S; Mortini P; Wass J; Giustina A; Lomba AA; Abucham J; Alvarez-Escola C; Barkan AL; Beckers A; Ben-Shlomo A; Bernabeu I; Bidlingmaier M; Biermasz N; Biller B; Boguszewski CL; Bolanowski M; Bollerslev J; Bonert V; Bronstein M; Bruno OD; Carmichael JD; Caron P; Chanson P; Casanueva FF; Clayton RN; Colao A; Cordido F; De Marinis L; Fahlbusch R; Fleseriu M; Formenti AM; Freda PU; Fukuoka H; Ghigo E; Greenman Y; Grineva E; Grossman A; Gurnell M; Heaney A; Hoffman AR; Ilovayskaya I; Johannsson G; Kadioglu P; Karavitaki N; Katznelson L; Kelestimur F; Kelly DF; Ho K; Krsek M; Lacroix A; Laws ER; StevenLoeffler J; Losa M; Jørgensen JO; Luger A; Mallea-Gil S; Mamelak A; Mazziotti G; McCormack A; Melmed S; Mercado M; Neggers S; Ning G; Oyesiku NM; Popovic V; Petakov M; Petersenn S; Pfeifer M; Pico A; Domingo MP; Raverot G; Reincke M; Gadelha MR; Salvatori R; Samson SL; Shimatsu A; Shimon I; Stewart P; Strasburger C; Swearingen B; Trainer P; Tritos NA; Tsagarakis S; van der Lely AJ; Vilar L; Villar-Taibo R; Zatelli MC, 2017, 'Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement', Pituitary, 20, pp. 489 - 498, http://dx.doi.org/10.1007/s11102-017-0838-2

McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P, 2017, 'Use of temozolomide in a large cohort of patients with aggressive pituitary tumours and pituitary carcinomas: Results from a European Society of Endocrinology (ESE) survey', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.49.oc12.2

De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI, 2017, 'Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours', European Journal of Endocrinology, 176, pp. 635 - 644, http://dx.doi.org/10.1530/EJE-16-0944

McCormack A, 2017, 'The role of genetic testing in pituitary tumours - who to test?', CLINICAL ENDOCRINOLOGY, 86, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000393453600087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Sousa SMC; Maiti K; Smith R; McCormack AI, 2016, 'Corticotrophin-releasing hormone (CRH) expression in the dermoid component of ovarian teratomas', Journal of the European Academy of Dermatology and Venereology, 30, pp. 867 - 869, http://dx.doi.org/10.1111/jdv.13035

Trainer P; Newell-Price J; Ayuk J; Aylwin S; Rees A; Drake W; Chanson P; Brue T; Webb S; Fajardo C; Aller J; McCormack A; Torpy D; Atley L; Tachas G, 2015, 'Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.38.p308

Trainer P; Newell-Price J; Ayuk J; Aylwin S; Rees A; Drake W; Chanson P; Brue T; Webb S; Fajardo C; Aller J; McCormack A; Torpy D; Tachas G; Atley L; Bidlingmaier M, 2015, 'A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly.', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.37.gp.19.10

De Sousa SMC; Earls P; McCormack AI, 2015, 'Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition', Endocrinology Diabetes and Metabolism Case Reports, 2015, pp. 150017, http://dx.doi.org/10.1530/edm-15-0017

Trainer PJ; Newell-Price J; Ayuk J; Aylwin S; Drake WM; Rees A; Chanson P; Brue T; Webb SM; Fajardo C; Aller J; McCormack A; Torpy DJ; Tachas G; Atley LM; Bidlingmaier M, 2014, 'OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly', Growth Hormone & IGF Research, 24, pp. s21, http://dx.doi.org/10.1016/s1096-6374(14)50054-8

Naziat A; Karavitaki N; Thakker R; Ansorge O; Sadler G; Gleeson F; Cranston T; McCormack A; Grossman AB; Shine B, 2013, 'Confusing genes: A patient with MEN2A and Cushing's disease', Clinical Endocrinology, 78, pp. 966 - 968, http://dx.doi.org/10.1111/cen.12072

McCormack A; Kaplan W; Gill AJ; Little N; Cook R; Robinson B; Clifton-Bligh R, 2013, 'MGMT expression and pituitary tumours: Relationship to tumour biology', Pituitary, 16, pp. 208 - 219, http://dx.doi.org/10.1007/s11102-012-0406-8

Shein TT; Costin ML; McCormack A; Parker A; Earls P, 2013, 'Atypical pituitary adenomas – investigation and validation of the 2004 who criteria', Pathology, 45, pp. s83 - s84, http://dx.doi.org/10.1097/01.pat.0000426942.30252.de

Rostomyan L; Daly A; Lila A; Lecoq A-L; Nachev E; Moraitis A; Naves L; Kranenburg D; Holdaway I; Filipponi S; Sievers C; Sahnoun-Fathallah M; Ojaniemi M; Sorkina E; Tichomirowa M; Ilovaiskaya I; Zacharin M; Bertherat J; Malchiodi E; Salvatori R; Barbosa SL-S; Maiter D; Mccormack A; Von Werder K; Rozhinskaya L; Dal J; Nazzari E; Auriemma R; Metzger D; Jorgensen JO; Dreval A; Ebeling T; Ferone D; Stalla G; Beck-Peccoz P; Aaltonen L; Colao A; Pronin V; Barlier A; Brue T; Rohmer V; Mukhopadhyay S; Borson-Chazot F; Neggers S; Jaffrain-Rea ML; Stratakis C; Chanson P; Zacharieva S; Petrossians P; Shah N; Beckers A, 2013, 'Le Gigantisme : les résultats d’une étude clinique et génétique internationale', Annales d Endocrinologie, 74, pp. 260 - 261, http://dx.doi.org/10.1016/j.ando.2013.07.083

Greenfield JR; Mccormack AI, 2012, 'Medication to prevent breast cancer too much to swallow?', Medical Journal of Australia, 196, pp. 314, http://dx.doi.org/10.5694/mja12.10056

McCormack A, 2012, 'Temozolomide in the treatment of aggressive pituitary tumours - an overview of existing knowledge and future perspectives', European Endocrinology, 8, pp. 116 - 121, http://dx.doi.org/10.17925/ee.2012.08.02.116

McCormack A, 2012, 'Temozolomide in the treatment of aggressive pituitary tumours - An overview of existing knowledge and future perspectives', European Neurological Review, 7, pp. 228 - 233, http://dx.doi.org/10.17925/enr.2012.07.04.228

McCormack A, 2012, 'Tmozolomide in the treatment of aggressive pituitary tumors - An overview of existing knowledge and future perspectives', US Endocrinology, 8, pp. 112 - 117, http://dx.doi.org/10.17925/use.2012.08.02.112

Mccromack A; Wass J; Grossman AB, 2011, 'Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status', European Journal of Clinical Investigation, 41, pp. 1133 - 1148

Thompson J; Collett L; Langbart M; Purcell NJ; Boyd SJ; Yuminaga Y; Mccromack A, 2011, 'Using the ISBAR handover tool in junior medical officer handover: a study in a Australian tertiary hospital', Postgraduate Medical Journal, 87, pp. 340 - 344, http://dx.doi.org/10.1136/pgmj.2010.105569

Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M, 2010, 'Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: Experience in six cases', European Journal of Endocrinology, 163, pp. 843 - 851, http://dx.doi.org/10.1530/EJE-10-0629

McCormack A, 2010, 'Adult pituitary disease', Australian Doctor, pp. 23 - 30

Glasziou P; Alexander J; Beller E; Clarke P; Chalmers J; MacMahon S; Cooper M; Ferrannini E; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Mogensen C; Neal B; Yu Pan C; Patel A; Poulter N; Rodgers A; William B; Woodward M; Collins R; Holman R; Sleight P; Adams M; Branley M; Fulcher G; Jenkins B; Louis D; Lou W; Lowe H; McCormack A; Mitchell P; Ong S; Pollock C; Watson J; Wong T; Allen S; Bompoint S; Carreras A; Chen T; Flynn S; Gibbo S; Han D; Hough S; Jayne K; Joshi R; Kengne AP; Linn J; Monaghan H; Ng R; Perkovic V; Regaglia J; Schmidt M; Xin D; Yufang B; Holloway T; Gray B; Milne A; Adderkin A; Guertin MR; de Guise D; Liyuan M; Reid J; Subramaniam R; Wen W; Williamson K, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, 5, pp. 21, http://dx.doi.org/10.1186/1477-7525-5-21

McCormack AI; Learoyd DL, 2006, 'A guide to thyroid dysfunction', Medicine Today, 7, pp. 28 - 35

Byrne MF; Chong HI; O'Donovan D; Sheehan KM; Leader MB; Kay E; McCormack A; Broe P; Murray FE, 2003, 'Idiopathic cholangiopathy in a biliary cast syndrome necessitating liver transplantation following head trauma', European Journal of Gastroenterology and Hepatology, 15, pp. 415 - 417, http://dx.doi.org/10.1097/00042737-200304000-00013

Back to profile page